Stem Cell Assay Market - Forecast to 2021

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, increasing investment in research related activities, and technological advancements are driving the growth in the global stem cell assay market. However, stringent regulatory policies and the high cost of stem cell based therapies are the major factors restraining the growth of this market.
The global stem cell assay market has been segmented on the basis of type of assay, kit, detection, instrument, application, end-user, and region. The viability/cytotoxicity segment is expected to account for the largest and fastest-growing segment of the global stem cell assay market in 2016. The increasing focus of the pharmaceutical industries on drug screening has resulted in the increase in demand for stem cell assays.
Based on kits, the stem cell assay market is segmented into adult stem cell kits and human embryonic stem Ccell kits. The adult stem cell kits are segmented into mesenchymal stem cell kits, induced pluripotent stem cell kits (IPSCs), hematopoietic stem cells kits, umbilical cord stem cell kits and neuronal stem cell kits. The adult stem cell kits segment is estimated to witness the highest CAGR during the forecast period, 2016 to 2021. The high growth in this segment is associated with the effectiveness of this type of kit in cellular analysis.
Based on detection, the global stem cell assay market has been segmented into instruments and detection kits. The instruments segment is anticipated to grow at the highest CAGR from 2016 to 2021. The high growth in this segment is due to the rising demand for instruments from the research and medical services.
On the basis application, the global stem cell assay market is segmented into regenerative medicine & therapy development, drug discovery and development and clinical research. The regenerative medicine & therapy development is further classified into orthopedic & musculoskeletal spine, cardiovascular, oncology, central nervous system, dermatology, diabetes and others. Among the applications, the regenerative medicine & therapy development segment is projected to witness the highest growth rate during the forecast period owing to the increase in incidences of chronic diseases which resulted in the increased demand for regenerative medicines.
Geographically, the global stem cell assay market is dominated by North America, followed by Europe, the Asia-Pacific region, and the Rest of the World (RoW). Growth in the North American region is due to the increasing incidence and prevalence of chronic diseases and an increasing patient pool in North American countries.
The major players in the global stem cell assay market include GE Healthcare (U.K.), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (U.S.), Cell Biolabs, Inc. (U.S.), Hemogenix Inc. (U.S.), STEMCELL Technologies Inc. (CA), Bio-Rad Laboratories, Inc. (U.S.), Bio-Techne Corporation (U.S.), and Cellular Dynamics International, Inc. (U.S.).
Research Coverage:
This report aims to provide insights on the global stem cell assay market. It provides valuable information on the type of assay, kit, detection, instrument, application, end-user, and regional segments of the global stem cell assay market. The report also covers the market dynamics which includes the drivers, restraints, opportunities and challenges of the global stem cell assay market. This report covers the competitive landscape of the top ten companies in the global stem cell assay market. The competitive landscape includes a comparison between the companies and the strategies adopted by them in order to continue their presence in the global stem cell assay market.

Value Addition for the Buyer:
The above mentioned information would benefit buyers by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years.
In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output, in order to remain successful in the global stem cell assay market.

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.3 MARKET SHARE ESTIMATION 22
2.3.1 KEY DATA FROM SECONDARY SOURCES 22
2.3.2 KEY DATA FROM PRIMARY SOURCES 23
2.3.3 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 ATTRACTIVE OPPORTUNITIES IN THE GLOBAL STEM CELL ASSAYS MARKET 27
4.2 REGIONAL ANALYSIS: STEM CELL ASSAYS MARKET, BY KITS, 2016 28
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.1.1 MARKET SEGMENTATION 31
5.1.2 MARKET DYNAMICS 34
5.1.3 DRIVERS 35
5.1.3.1 Increased research activities pertaining to stem cell assays 35
5.1.3.2 Technological advancements and introduction of new products 36
5.1.3.3 Increased funding from governments, venture capitalists, and private organizations for stem cell research 36
5.1.4 RESTRAINTS 37
5.1.4.1 Affordability of stem cell therapies & treatments 37
5.1.4.2 Slow response time of regulatory bodies & training needs 37
5.1.5 OPPORTUNITIES 37
5.1.5.1 Evolving market & fast changing market dynamics 37
?
5.1.6 CHALLENGES 37
5.1.6.1 Unapproved stem cell operations 37
6 STEM CELL ASSAYS MARKET, BY TECHNOLOGY 38
6.1 TECHNOLOGY ROADMAP 39
6.1.1 MICRO FABRICATED ASSISTED TECHNOLOGY 40
6.1.1.1 Microfluidics-based cell trap technologies 40
6.1.1.2 Droplet-based microfluidic technology 40
6.1.1.3 Microwell-based analysis system 41
6.1.2 TECHNOLOGY IN DEVELOPMENT 41
6.1.2.1 Bead-based multiplex assays 41
6.1.2.2 Bioanalytical Nanotechnology 42
7 GLOBAL STEM CELL ASSAYS MARKET, BY ASSAY TYPE 43
7.1 INTRODUCTION 44
7.1.1 CELL VIABILITY & CYTOTOXICITY ASSAYS 45
7.1.2 ISOLATION & PURIFICATION ASSAYS 46
7.1.3 CELL IDENTIFICATION ASSAYS 47
7.1.4 CELL PROLIFERATION ASSAYS 48
7.1.5 CELL DIFFERENTIATION ASSAYS 49
7.1.6 CELL FUNCTION ASSAYS 50
7.1.7 CELL APOPTOSIS ASSAYS 51
8 GLOBAL STEM CELL ASSAYS MARKET, BY KITS 52
8.1 INTRODUCTION 53
8.2 ADULT STEM CELL KITS 54
8.2.1 MESENCHYMAL STEM CELL KITS 56
8.2.2 INDUCED PLURIPOTENT STEM CELL KITS 57
8.2.3 HEMATOPOIETIC STEM CELL KITS 58
8.2.4 NEURAL STEM CELLS KITS 59
8.2.5 UMBILICAL CORD STEM CELLS KITS 60
8.3 HUMAN EMBRYONIC STEM CELLS KITS 61
9 GLOBAL STEM CELL ASSAYS MARKET, BY PRODUCT 62
9.1 INTRODUCTION 63
9.2 INSTRUMENTS 64
9.2.1 MICROELECTRODE ARRAYS 65
9.2.2 FLOW CYTOMETER 66
9.2.3 CELL IMAGING SYSTEMS 67
9.2.4 AUTOMATED CELL COUNTER 68
9.3 DETECTION KITS 69
9.3.1 IMMUNO HISTOCHEMISTRY KITS 69
10 STEM CELL ASSAYS MARKET, BY APPLICATION 70
10.1 INTRODUCTION 71
10.2 REGENERATIVE MEDICINE & THERAPY DEVELOPMENT 73
10.2.1 ORTHOPEDIC & MUSCULOSKELETAL SPINE 76
10.2.2 DERMATOLOGY 77
10.2.3 CARDIOVASCULAR 78
10.2.4 CENTRAL NERVOUS SYSTEM 79
10.2.5 ONCOLOGY 80
10.2.6 DIABETES 81
10.2.7 OTHERS 82
10.3 DRUG DISCOVERY & DEVELOPMENT 83
10.4 CLINICAL RESEARCH 84
11 GLOBAL STEM CELL ASSAYS MARKET, BY END USER 85
11.1 INTRODUCTION 86
11.2 RESEARCH INSTITUTES 87
11.3 INDUSTRY RESEARCH 87
12 REGIONAL ANALYSIS 88
12.1 INTRODUCTION 89
12.2 NORTH AMERICA 90
12.3 EUROPE 96
12.4 ASIA-PACIFIC 102
12.5 REST OF THE WORLD (ROW) 107
13 COMPETITIVE LANDSCAPE 111
13.1 OVERVIEW 111
13.2 MARKET SHARE ANALYSIS 112
13.3 COMPETITIVE SITUATION AND TRENDS 113
13.3.1 NEW PRODUCT LAUNCHES 114
13.3.2 AGREEMENTS 116
13.3.3 OTHER DEVELOPMENTS 117
14 COMPANY PROFILES 118
(Overview, Products and Services, Financials, Strategy & Development)*
14.1 INTRODUCTION 118
14.2 GE HEALTHCARE 119
14.3 PROMEGA CORPORATION 121
14.4 THERMO FISHER SCIENTIFIC INC. 123
14.5 MERCK MILLIPORE (MERCK KGAA) 125
14.6 CELL BIOLABS, INC. 127
14.7 HEMOGENIX INC. 128
14.8 STEMCELL TECHNOLOGIES INC. 130
14.9 BIO-RAD LABORATORIES 132
14.10 R&D SYSTEMS 134
14.11 CELLULAR DYNAMICS INTERNATIONAL 136
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
15 APPENDIX 137
15.1 INSIGHTS FROM INDUSTRY EXPERTS 137
15.2 DISCUSSION GUIDE 138
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143
15.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 145
15.5 AVAILABLE CUSTOMIZATIONS 146
15.6 RELATED REPORTS 146